Cargando…
Sequenced Combinations of Cisplatin and Selected Phytochemicals towards Overcoming Drug Resistance in Ovarian Tumour Models
In the present study, cisplatin, artemisinin, and oleanolic acid were evaluated alone, and in combination, on human ovarian A2780, A2780(ZD0473R), and A2780(cisR) cancer cell lines, with the aim of overcoming cisplatin resistance and side effects. Cytotoxicity was assessed by MTT reduction assay. Co...
Autores principales: | Althurwi, Safiah Ibrahim, Yu, Jun Q., Beale, Philip, Huq, Fazlul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589098/ https://www.ncbi.nlm.nih.gov/pubmed/33053689 http://dx.doi.org/10.3390/ijms21207500 |
Ejemplares similares
-
Carboplatin and oxaliplatin in sequenced combination with bortezomib in ovarian tumour models
por: Al-Eisawi, Zaynab, et al.
Publicado: (2013) -
Synthesis and activity of three new trinuclear platinums with cis-geometry for terminal metal centres
por: Hamad, Shahnaz A, et al.
Publicado: (2014) -
Enhanced Accumulation of Cisplatin in Ovarian Cancer Cells from Combination with Wedelolactone and Resulting Inhibition of Multiple Epigenetic Drivers
por: Sarwar, Sadia, et al.
Publicado: (2021) -
Synergistic Cytotoxic Effect from Combination of Wedelolactone and Cisplatin in HeLa Cell Line: A Novel Finding
por: Sarwar, Sadia, et al.
Publicado: (2020) -
Mithramycin and Analogs for Overcoming Cisplatin Resistance in Ovarian Cancer
por: Schweer, David, et al.
Publicado: (2021)